After raking in enormous profits from its coronavirus vaccine in 2021, the U.S.-based pharmaceutical giant Pfizer has kicked off the New Year by hiking the prices of more than 120 of its drugs, resulting in significantly higher costs for patients amid a deadly pandemic.

AE/ME